Clinical Trials Directory

Trials / Completed

CompletedNCT01701115

Effect of Local Anesthetic Dose on Interscalene Block

Effect of Local Anesthetic Dose on Interscalene Block for Shoulder Arthroscopy, Patient Satisfaction and Return of Handgrip Strength

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
154 (actual)
Sponsor
Hospital for Special Surgery, New York · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if a decrease in the standard volume of local anesthetic used to numb your shoulder area before shoulder arthroscopy will provide adequate anesthesia for the procedure and decrease the amount of time until you are ready for discharge from the hospital.

Detailed description

Traditionally, an interscalene block is done either with nerve stimulator or ultrasound guided using 40-60mL of local anesthetic. The study plans to investigate the difference in hand grip strength post-operatively in patients who will receive interscalene blocks with 40mL versus a lower dose (20mL) of local anesthetic. We suspect the lower dose will achieve adequate surgical anesthesia while creating less motor block and thus, increase patient satisfaction, present fewer complications or adverse affects and decrease time in the recovery room.

Conditions

Interventions

TypeNameDescription
PROCEDURELow Dose (20 ml) Local Anesthetic Volume for Interscalene BlockAnesthetic volume: Investigational group: A 1:1 Mepivacaine 1.5%: Bupivacaine 0.5% mixture for a total of 20 mL
PROCEDUREControl Dose (40 mL) Local Anesthetic Volume for Interscalene BlockAnesthetic volume: Control group: A 1:1 Mepivacaine 1.5%: Bupivacaine 0.5% mixture for a total of 40 mL
DRUGLow Dose (20 mL) Local Anesthetic (Mepivacaine:Bupivacaine)
DRUGControl Dose (40 mL) Local Anesthetic (Mepivacaine:Bupivacaine)

Timeline

Start date
2012-08-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2012-10-04
Last updated
2017-10-04
Results posted
2017-10-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01701115. Inclusion in this directory is not an endorsement.